COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:15, il y a 4 mois 17 jours NuRAN Announces Closing of the Restructuring Transaction and Initial Tranche of Additional Debt Settlements NuRAN Wireless Inc. announces successful Closure of Restructuring Transaction and appointment of new director, Joseph Labkowski. Company focuses on rural telecommunications infrastructure Telecommunications NuRAN Wireless Restructuring Transaction Rural Regions Joseph Labkowski
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:06, il y a 4 mois 17 jours Communiqué de presse : Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI) Wayrilz de Sanofi approuvé dans l’UE comme premier inhibiteur de la BTK pour le traitement de la thrombocytopénie immunitaire (TPI). Nouvelle approche novatrice ciblant les causes sous-jacentes de la TPI Traitement Wayrilz Thrombocytopénie Immunitaire BTK Inhibiteur
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:06, il y a 4 mois 17 jours Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Sanofi's Wayrilz, a novel BTK inhibitor, approved in the EU for treating immune thrombocytopenia. Offers multi-immune modulation for ITP management Sanofi BTK Inhibitor Wayrilz Immune Thrombocytopenia Multi-immune Modulation
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 15:05, il y a 4 mois 17 jours Precisely Achieves ISO/IEC 27701 Certification, Strengthening Its Global Privacy Framework Precisely achieves ISO/IEC 27701 certification, enhancing global privacy framework with rigorous privacy standards and accountability for personal data processing Compliance Privacy Data Integrity Precisely ISO/IEC 27701 Certification
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:53, il y a 4 mois 17 jours Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces New CEO Investment Nextech3D.ai confirms successful completion of due diligence for Krafty Labs acquisition, CEO to invest $321,917 through convertible note, reinforcing commitment to shareholders Nextech3D.ai CEO Investment Krafty Labs Acquisition AI-first Event Technology Insider Investment
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:36, il y a 4 mois 17 jours DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and academic partners introduce groundbreaking percutaneous platform for organ-specific delivery of advanced therapies, addressing critical challenges in gene and cell therapy development Advanced Therapies DiNAQOR Academic Partners Percutaneous Platform Organ-specific Delivery
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:34, il y a 4 mois 17 jours Targeted adjustment of economic bond terms achieved paragon GmbH & Co. KGaA achieves targeted adjustment of economic bond terms approved by bondholders, including extension of term and waiver of PIK interest element Bondholders Paragon GmbH & Co. KGaA Extension PIK Interest Economic Terms
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:30, il y a 4 mois 17 jours Ørsted brings in Cathay as investor in Greater Changhua 2 Offshore Wind Farm in Taiwan Ørsted partners with Cathay Life Insurance for Greater Changhua 2 Offshore Wind Farm in Taiwan. Joint venture strengthens capital structure and supports renewable energy transition in Taiwan Renewable Energy Ørsted Offshore Wind Farm Taïwan Cathay Life Insurance
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:13, il y a 4 mois 17 jours Hanseatic Global Terminals to invest in greenfield container terminal project in Brazil Hanseatic Global Terminals to invest in greenfield container terminal project in Brazil with Imetame Group. New modern transshipment hub and gateway port planned for Aracruz by 2028 Investment Brazil Container Terminal Hanseatic Global Terminals Imetame Group
COMMUNIQUÉ DE PRESSE publié le 23/12/2025 à 14:02, il y a 4 mois 17 jours FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner FDA approves Formycon's Nufymco® as interchangeable Ranibizumab Biosimilar, partnering with Zydus for commercialization in the US, expanding access to retinal therapies FDA Approval Formycon Zydus Interchangeable Biosimilar Nufymco®
Publié le 07/05/2026 à 19:15, il y a 1 jour 22 heures 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Publié le 07/05/2026 à 19:15, il y a 1 jour 22 heures Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Publié le 07/05/2026 à 19:06, il y a 1 jour 22 heures Disclosure of Share Capital and Voting Rights as of April 30, 2026
Publié le 07/05/2026 à 19:06, il y a 1 jour 22 heures Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Publié le 07/05/2026 à 19:00, il y a 1 jour 22 heures ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 09/05/2026 à 01:30, il y a 16 heures 12 minutes Star Copper Announces Agreement with Zimtu Capital Corp.
Publié le 09/05/2026 à 00:00, il y a 17 heures 42 minutes Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Publié le 08/05/2026 à 20:38, il y a 21 heures 4 minutes EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Publié le 08/05/2026 à 19:12, il y a 22 heures 29 minutes EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Publié le 08/05/2026 à 19:02, il y a 22 heures 40 minutes Metall Zug – Annual General Meeting of Shareholders approves all proposals